Study of AlloGen® Liquid Intra-articular Injection for Knee Osteoarthritis
Status:
Withdrawn
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled trial comparing a single intra-articular
injection of 2.0 mL AlloGen vs 2.0 mL sterile saline. Patients will be evaluated at baseline,
1 week, 6 weeks, 12 weeks, and 26 weeks.